{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:50:03Z","timestamp":1779879003624,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jpag.2013.09.015","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T14:11:54Z","timestamp":1399558314000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"27","author":[{"given":"Gaspare","family":"Stabile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Borrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Carducci","family":"Artenisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Maria","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibale","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonsa","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2013.09.015_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2013.09.015_bib3","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jpag.2013.09.015_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jpag.2013.09.015_bib5","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib6","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2013.09.015_bib9","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome","volume":"18","author":"Allen","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09513590701214398","article-title":"Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia","volume":"23","author":"Genazzani","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2013.09.015_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/ann.34.3.217.224","article-title":"Glitazones: clinical effects and molecular mechanisms","volume":"34","author":"Stumvoll","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.jpag.2013.09.015_bib13","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09513590500430575","article-title":"Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome","volume":"21","author":"Garmes","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2013.09.015_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09513590701492689","article-title":"Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations","volume":"23","author":"Koo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2013.09.015_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2008-1133","article-title":"Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial","volume":"94","author":"Aroda","year":"2009","journal-title":"Clin Endocrinol Metab"},{"issue":"40","key":"10.1016\/j.jpag.2013.09.015_bib17","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","article-title":"Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis","volume":"277","author":"Matsuda","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpag.2013.09.015_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-003-1228-z","article-title":"Regulation of adipocytokines and insulin resistance","volume":"46","author":"Fasshauer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpag.2013.09.015_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","article-title":"Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome","volume":"61","author":"Spranger","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2013.09.015_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1291\/hypres.31.229","article-title":"Adiponectin levels associated with the development of hypertension: a prospective study","volume":"31","author":"Imatoh","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jpag.2013.09.015_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.1.01868","article-title":"Evidence for altered adipocyte function in polycystic ovary syndrome","volume":"152","author":"Carmina","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpag.2013.09.015_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2265.2007.03015.x","article-title":"Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome","volume":"68","author":"Glintborg","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpag.2013.09.015_bib23","first-page":"412","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.jpag.2013.09.015_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2013.09.015_bib25","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"23","author":"De Fronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jpag.2013.09.015_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/EJE-08-0272","article-title":"Monogenic polycystic ovary syndrome due to a mutation in the lamin A\/C gene is sensitive to thiazolidinediones but not to metformin","volume":"159","author":"Gambineri","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpag.2013.09.015_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.fertnstert.2010.06.058","article-title":"of the insulin sensitiziers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study","volume":"95","author":"Naka","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2013.09.015_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonz\u00e1lez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib29","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2013.09.015_bib30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.ATV.21.6.961","article-title":"Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity","volume":"21","author":"Lemieux","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpag.2013.09.015_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.fertnstert.2010.06.058","article-title":"Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study","volume":"95","author":"Naka","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2013.09.015_bib32","doi-asserted-by":"crossref","first-page":"28.e1","DOI":"10.1016\/j.ajog.2007.09.014","article-title":"How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?","volume":"198","author":"Rizzo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2013.09.015_bib33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women\u00a0with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2013.09.015_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/03007995.2012.681636","article-title":"A systematic review and meta-analysis of\u00a0randomized controlled trials comparing pioglitazone versus metformin in\u00a0the\u00a0treatment of polycystic ovary syndrome","volume":"28","author":"Du","year":"2012","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881300301X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108331881300301X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:41:33Z","timestamp":1761054093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108331881300301X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S108331881300301X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2013.09.015","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2013.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}